24
Participants
Start Date
October 31, 2011
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Aliskiren
Drug therapy will be started with an initial 2 weeks on Aliskiren 150 mg followed by a titration to 300 mg Aliskiren if the treatment is well tolerated. A first baseline measurements will be performed before initiating therapy and a second after 8 weeks of treatment (24h after last drug intake) to assess the chronic effect.
Hydrochlorothiazide
Drug therapy will be started with an initial 2 weeks HCTZ 12.5 mg followed by a titration to 25 mg HCTZ if the treatment is well tolerated. A first baseline measurements will be performed before initiating therapy and a second after 8 weeks of treatment (24h after last drug intake) to assess the chronic effect.
Centre Hospitalier Universitaire Vaudois, Lausanne
Centre Hospitalier Universitaire Vaudois
OTHER